Related Experiment Video
Updated: Jun 16, 2026
03:53
Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Alternatively spliced isoforms of tissue factor pathway inhibitor
Susan A Maroney1, Paul E Ellery, Alan E Mast
1Blood Research Institute, Blood Center of Wisconsin, 8727 Watertown Plank Road, Milwaukee, WI 53226-3548, USA.
Thrombosis Research
|February 24, 2010
Summary
Tissue factor pathway inhibitor (TFPI) regulates blood clotting. TFPI isoform production differs between humans and mice, with TFPIbeta being dominant in mice, suggesting translational regulation.
Area of Science:
- Hemostasis and Thrombosis
- Molecular Biology
- Biochemistry
Background:
- Tissue factor pathway inhibitor (TFPI) is a key regulator of the extrinsic coagulation pathway.
- TFPI functions by inhibiting the tissue factor (TF)/factor VIIa (fVIIa) complex in a factor Xa (fXa)-dependent manner.
- TFPI is produced by various cells, including endothelial cells, and is crucial for preventing excessive blood clotting, as evidenced by TFPI knockout mouse lethality.
Purpose of the Study:
- To investigate the differential expression and regulation of TFPI isoforms (TFPIalpha, TFPIbeta) in humans and mice.
- To determine the predominant TFPI protein isoform in adult mice.
- To explore the translational regulation of TFPI isoform production.
Main Methods:
- Analysis of TFPI mRNA and protein expression in human and mouse tissues.
- Comparison of TFPI isoform levels between species.
- Investigation of translational control mechanisms.
Main Results:
- Both human and mouse tissues express significantly more TFPIalpha mRNA than TFPIbeta mRNA.
- TFPIalpha is the predominant protein isoform in humans.
- TFPIbeta is identified as the major protein isoform in adult mice, despite lower mRNA levels.
Conclusions:
- TFPI isoform production is subject to translational regulation, leading to distinct protein expression patterns in different species.
- TFPIbeta is the predominant functional isoform in adult mice.
- Understanding species-specific TFPI isoform regulation is critical for interpreting studies and developing anticoagulant therapies.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...